Search results for "Highlights"
For colonoscopy prep, low-volume, same-day dosing appears as effective as split dosing
A randomized trial of three polyethylene glycol regimens found that more patients tolerated and were willing to repeat low-volume same-day or split-dose prep compared to high-volume split-dose regimens.
https://gastroenterology.acponline.org/archives/2020/08/28/3.htm
28 Aug 2020
Rivaroxaban associated with increased risk for GI bleeding compared to other DOACs
A study in Iceland of direct oral anticoagulants (DOACs) found a higher risk for overall and major GI bleeding with rivaroxaban than with either apixaban or dabigatran.
https://gastroenterology.acponline.org/archives/2021/10/22/1.htm
22 Oct 2021
AASLD offers guidance on reproductive health and liver disease
Menopausal hormone therapy should not be used in women with decompensated liver function, Budd-Chiari syndrome, or hepatocellular adenomas, the American Association for the Study of Liver Diseases (AASLD) said, among other recommendations.
https://gastroenterology.acponline.org/archives/2020/09/25/2.htm
25 Sep 2020
Cannabis, cannabinoids didn't improve remission or inflammatory markers in IBD
A meta-analysis of inflammatory bowel disease (IBD) studies did find improvements in patient-reported symptoms and quality of life associated with cannabis and cannabinoids.
https://gastroenterology.acponline.org/archives/2020/07/24/3.htm
24 Jul 2020
CDC updates guidance on responding to health care exposures to HCV
The CDC called for hepatitis C virus (HCV) testing of both the patient and exposed personnel as soon as possible after an exposure incident, preferably within 48 hours.
https://gastroenterology.acponline.org/archives/2020/08/28/2.htm
28 Aug 2020
PPIs in patients receiving anticoagulation may not reduce upper GI events
There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
https://gastroenterology.acponline.org/archives/2019/05/24/3.htm
24 May 2019
COVID-19 mRNA vaccines appear effective in patients with cirrhosis
A retrospective cohort study compared outcomes among U.S. veterans with cirrhosis who received at least one dose of an mRNA COVID-19 vaccine with those of a propensity-matched control group of unvaccinated patients at similar risk.
https://gastroenterology.acponline.org/archives/2021/07/23/1.htm
23 Jul 2021
Steroids may not be needed with anti-TNF induction in Crohn's disease
Rates of clinical remission and clinical response were 32.0% and 42.7%, respectively, in Crohn's disease patients receiving therapy with both corticosteroids and anti-tumor necrosis factor (TNF) agents and 35.5% and 46.8% in those receiving only anti-TNF agents, a systematic review and meta-analysis found.
https://gastroenterology.acponline.org/archives/2020/06/26/3.htm
26 Jun 2020
Liver cancer diagnosis delayed in almost half of veterans with cirrhosis
Failure to follow guidelines, diagnostic imaging without alpha-fetoprotein measurement, and diagnosis from an incidental finding were all associated with a delay of more than 60 days between a red flag for hepatocellular carcinoma and a diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/07/24/2.htm
24 Jul 2020
Patients with IBD who catch COVID-19 have high clot risk, study finds
Infection with SARS-CoV-2 was associated with an eightfold increase in the risk of venous thromboembolism among patients with inflammatory bowel disease (IBD), but the risk was mitigated by chronic anticoagulation, according to a retrospective study.
https://gastroenterology.acponline.org/archives/2021/06/25/1.htm
25 Jun 2021